EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PBTK model-based analysis of CYP3A4 induction and the toxicokinetics of the pyrrolizidine alkaloid retrorsine in man

Anja Lehmann, Ina Geburek, Stefanie Hessel-Pras, Anne-Margarethe Enge, Hans Mielke, Christine Müller-Graf, Charlotte Kloft, Christoph Hethey

Archives of Toxicology · 2024

DOI: 10.1007/s00204-024-03698-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2024. Verfasst von Anja Lehmann und 7 weiteren Autor:innen. Beteiligte Einrichtung: German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. Hauptthemen laut MEDLINE: Cytochrome P-450 CYP3A, Cytochrome P-450 CYP3A Inducers, Models, Biological, Pyrrolizidine Alkaloids. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bundesinstitut für Risikobewertung (BfR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cytochrome P450 (CYP)3A4 induction by drugs and pesticides plays a critical role in the enhancement of pyrrolizidine alkaloid (PA) toxicity as it leads to increased formation of hepatotoxic dehydro-PA metabolites. Addressing the need for a quantitative analysis of this interaction, we developed a physiologically-based toxicokinetic (PBTK) model. Specifically, the model describes the impact of the well-characterized CYP3A4 inducer rifampicin on the kinetics of retrorsine, which is a prototypic PA and contaminant in herbal teas. Based on consumption data, the kinetics after daily intake of retrorsine were simulated with concomitant rifampicin treatment. Strongest impact on retrorsine kinetics (plasma AUC $$_{24}$$ 24 and $$C_{{\text {max}}}$$ C max reduced to 67% and 74% compared to the rifampicin-free reference) was predicted directly after withdrawal of rifampicin. At this time point, the competitive inhibitory effect of rifampicin stopped, while CYP3A4 induction was still near its maximum. Due to the impacted metabolism kinetics, the cumulative formation of intestinal retrorsine CYP3A4 metabolites increased to 254% (from 10 to 25 nmol), while the cumulative formation of hepatic CYP3A4 metabolites was not affected (57 nmol). Return to baseline PA toxicokinetics was predicted 14 days after stop of a 14-day rifampicin treatment. In conclusion, the PBTK model showed to be a promising tool to assess the dynamic interplay of enzyme induction and toxification pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytochrome P-450 CYP3ACytochrome P-450 CYP3A InducersModels, BiologicalPyrrolizidine AlkaloidsRifampinToxicokineticsHumansMaleDrug InteractionsLiver

Stichwörter der Autor:innen

BioactivationDrug–drug interactionEnzyme inductionPBPK modelRifampicin

Substanzen

CYP3A4 protein, humanCytochrome P-450 CYP3ACytochrome P-450 CYP3A InducersPyrrolizidine AlkaloidsretrorsineRifampin

Autor:innen und Institutionen

  • German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany.
  • Department of Clinical Pharmacy and Biochemistry, Institute of Pharmacy, Freie Universitaet Berlin, 12169, Berlin, Germany.
  • German Federal Institute for Risk Assessment (BfR), Max-Dohrn-Str. 8-10, 10589, Berlin, Germany. hans.mielke@bfr.bund.de.

Förderung

  • Bundesinstitut für Risikobewertung (BfR)

Zitieren

APA

Lehmann, A., Geburek, I., Hessel-Pras, S., Enge, A. M., Mielke, H., Müller-Graf, C., Kloft, C., & Hethey, C. (2024). PBTK model-based analysis of CYP3A4 induction and the toxicokinetics of the pyrrolizidine alkaloid retrorsine in man. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03698-2

Vancouver

Lehmann A, Geburek I, Hessel-Pras S, Enge AM, Mielke H, Müller-Graf C, et al. PBTK model-based analysis of CYP3A4 induction and the toxicokinetics of the pyrrolizidine alkaloid retrorsine in man. Archives of Toxicology. 2024. doi:10.1007/s00204-024-03698-2

BibTeX
@article{Lehmann2024,
  author = {Lehmann, Anja and Geburek, Ina and Hessel-Pras, Stefanie and Enge, Anne-Margarethe and Mielke, Hans and Müller-Graf, Christine and Kloft, Charlotte and Hethey, Christoph},
  title = {PBTK model-based analysis of CYP3A4 induction and the toxicokinetics of the pyrrolizidine alkaloid retrorsine in man},
  journal = {Archives of Toxicology},
  year = {2024},
  doi = {10.1007/s00204-024-03698-2}
}
Kostenlos starten →